feed,title,long_url,short_url
Benzinga,"FBX Report: October 04, 2021",https://benzinga.com/news/earnings/21/10/23216910/fbx-report-october-04-2021,https://j.mp/3iwfSt0
Benzinga,"JNJ, Xencor Sign $1.3B Licensing Deal For B-Cell Malignancies-Targeted Bispecific Antibody",https://benzinga.com/general/biotech/21/10/23218310/jnj-xencor-sign-1-3b-licensing-deal-for-b-cell-malignancies-targeted-bispecific-antibody,https://j.mp/3FiNuoj
Benzinga,J&J's RSV Vaccine Candidate Shows 80% Efficacy In Older Adults,https://benzinga.com/general/biotech/21/10/23212050/j-js-rsv-vaccine-candidate-shows-80-efficacy-in-older-adults,https://j.mp/3FgNODW
